Cited 16 times in
Use of Natural Compounds as a potential therapeutic agent against COVID-19
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 동재준 | - |
dc.date.accessioned | 2021-04-29T16:58:03Z | - |
dc.date.available | 2021-04-29T16:58:03Z | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 1381-6128 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/182110 | - |
dc.description.abstract | The current 2019-nCoV outbreak is becoming extremely noxious and has affected the whole world. Its control is challenging because there is no effective vaccine or drug available for Coronavirus disease. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), previously named as 2019 novel Coronavirus (2019-nCoV), primarily targets the human respiratory system to lung lesions and lethal pneumonia. Natural products have always shown a crucial role in the process of drug development against various diseases. They could be leads for further drug development to combat emergent mutants of the coronavirus. In this review, the current status of natural compounds and their derivatives acting against different species of CoV are discussed. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Bentham Science Publishers | - |
dc.relation.isPartOf | CURRENT PHARMACEUTICAL DESIGN | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Use of Natural Compounds as a potential therapeutic agent against COVID-19 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Family Medicine (가정의학교실) | - |
dc.contributor.googleauthor | Shadma Wahab | - |
dc.contributor.googleauthor | Irfan Ahmad | - |
dc.contributor.googleauthor | Safia Irfan | - |
dc.contributor.googleauthor | Mohammad Hassan Baig | - |
dc.contributor.googleauthor | Abd-ElAziem Farouk | - |
dc.contributor.googleauthor | Jae-Jun Dong | - |
dc.identifier.doi | 10.2174/1381612826666210101154118 | - |
dc.contributor.localId | A04927 | - |
dc.relation.journalcode | J00681 | - |
dc.identifier.eissn | 1873-4286 | - |
dc.identifier.pmid | 33388014 | - |
dc.identifier.url | https://www.eurekaselect.com/189820/article | - |
dc.subject.keyword | Antivirals | - |
dc.subject.keyword | COVID19 | - |
dc.subject.keyword | Dietary supplements | - |
dc.subject.keyword | Natural products | - |
dc.subject.keyword | Phytotherapy | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.contributor.alternativeName | Dong, Jae June | - |
dc.contributor.affiliatedAuthor | 동재준 | - |
dc.citation.volume | 27 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1144 | - |
dc.citation.endPage | 1152 | - |
dc.identifier.bibliographicCitation | CURRENT PHARMACEUTICAL DESIGN, Vol.27(9) : 1144-1152, 2021-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.